RxSight Grants Inducement Stock Options
The Aliso Viejo-based firm awarded equity to two new employees as an employment inducement.
Updated on Oct. 24, 2026 in Stock Picks
Live Poll
Do you believe companies should provide significant stock-based incentives to attract new executive or non-executive talent?
RxSight has granted stock options for 236,456 shares of common stock to two new employees. These inducement awards follow Nasdaq Listing Rule 5635(c)(4).
Why it matters
Equity grants are used as strategic incentives to secure talent. These specific awards help align the financial interests of new hires with the company's long-term performance.
The stock options are priced at $5.02 per share, with 25% of the total grant vesting on the one-year anniversary. The company also intends to issue 637,449 restricted stock units on or about November 3, 2026.
The players
RxSight
An Aliso Viejo-based ophthalmic medical technology company that develops and markets adjustable intraocular lenses.
The details
The options will continue vesting monthly for three years following the initial one-year cliff. Separately, the upcoming restricted stock units are set to vest in six equal installments, concluding on August 31, 2029.
Timeline
October 23, 2026: RxSight granted the inducement stock options.
November 3, 2026: The company plans to grant restricted stock units.
February 28, 2027: The first vesting installment for the units is scheduled.
August 31, 2029: The final vesting installment for the units will occur.
Market Dynamics
The grant complies with Nasdaq Listing Rule 5635(c)(4), a regulatory framework that permits the issuance of equity as a material inducement for new hires. This mechanism allows firms to bypass shareholder approval for specific compensation packages needed to recruit specialized executive talent.
The issuance of these shares increases the total count of outstanding common stock for the company. Retail investors should account for this potential dilution when evaluating the long-term value of their holdings.
The takeaway
Companies frequently use tiered vesting schedules to encourage employee retention over several years. New hires often receive a mix of options and restricted units to balance immediate incentives with long-term company loyalty.
What happens next
RxSight is scheduled to grant 637,449 restricted stock units on or about November 3, 2026, with the first vesting installment expected on February 28, 2027.
Further reading
Find more details on local investment activity in Aliso Viejo Stock Picks.
Source note: This article includes information reported by The Manila times.
Live Poll
Do you believe companies should provide significant stock-based incentives to attract new executive or non-executive talent?
